Showing results (1551-1560 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|September 13, 2014
MMPs: a novel drug target for schizophreniaKanwaljit Chopra, Ankita Baveja, Anurag KuhadExpert Opinion on Therapeutic Targets|September 10, 2014
Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cellsKimberley Joanne Hatfield, Håkon Reikvam, Øystein BruserudExpert Opinion on Therapeutic Targets|September 19, 2014
Targeting FLT3 to treat leukemiaHeiko Konig, Mark LevisExpert Opinion on Therapeutic Targets|August 12, 2014
Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expressionChiao-Wen Lin, Ying-Erh Chou, Hui-Ling Chiou, et al.Expert Opinion on Therapeutic Targets|August 1, 2014
The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic targetWen-Yue Liu, Sha Huang, Ke-Qing Shi, et al.Expert Opinion on Therapeutic Targets|July 25, 2014
Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorderRafael T de Sousa, Rodrigo Machado-Vieira, Carlos A Zarate, et al.Expert Opinion on Therapeutic Targets|August 22, 2014
DNMTs as potential therapeutic targets in high-risk pediatric embryonal brain tumorsPatrick Sin-Chan, Annie HuangExpert Opinion on Therapeutic Targets|August 30, 2013
Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapyGeorge S Krasnov, Alexey A Dmitriev, Valentina A Lakunina, et al.Expert Opinion on Therapeutic Targets|September 3, 2013
Type 3 deiodinase and solid tumors: an intriguing pairMonica Dentice, Dario Antonini, Domenico SalvatoreExpert Opinion on Therapeutic Targets|September 3, 2013
Targeting the somatostatin receptor in pituitary and neuroendocrine tumorsMarije J Veenstra, Wouter W de Herder, Richard A Feelders, et al.Pageof 232